{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:18:37Z","timestamp":1793384317381,"version":"4.5.0"},"reference-count":42,"publisher":"Japanese Society of Veterinary Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1292\/jvms.19-0450","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T22:06:56Z","timestamp":1583878016000},"page":"467-474","source":"Crossref","is-referenced-by-count":14,"title":["Effect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes"],"prefix":"10.1292","volume":"82","author":[{"given":"Noha","family":"SAYED","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-8509, Japan"},{"name":"Clinical Pathology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"ABDALLA","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia","family":"KILANY","sequence":"additional","affiliation":[{"name":"Clinical Pathology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"DESSOUKI","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"YOSHIDA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pathology, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"SASAKI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"SHIMODA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-8509, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Baskol, G., Baskol, M. and Kocer, D. 2007. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. <i>Clin. Biochem.<\/i> 40: 776\u2013780.","DOI":"10.1016\/j.clinbiochem.2007.02.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Blondel, O., Bailbe, D. and Portha, B. 1990. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. <i>Metabolism<\/i> 39: 787\u2013793.","DOI":"10.1016\/0026-0495(90)90120-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Caramori, M. L. and Mauer, M. 2003. Diabetes and nephropathy. <i>Curr. Opin. Nephrol. Hypertens.<\/i> 12: 273\u2013282.","DOI":"10.1097\/00041552-200305000-00008"},{"key":"4","unstructured":"4. Coskun, O., Kanter, M., Korkmaz, A. and Oter, S. 2005. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. <i>Pharmacol. Res.<\/i> 51: 117\u2013123."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cryer, P. E. 2004. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. <i>N. Engl. J. Med.<\/i> 350: 2272\u20132279.","DOI":"10.1056\/NEJMra031354"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cryer, P. E. 2009. Preventing hypoglycaemia: what is the appropriate glucose alert value? <i>Diabetologia<\/i> 52: 35\u201337.","DOI":"10.1007\/s00125-008-1205-7"},{"key":"7","unstructured":"7. Culotta, V. C. 2000. Superoxide dismutase, oxidative stress, and cell metabolism. <i>Curr. Top. Cell. Regul.<\/i> 36: 117\u2013132."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Daneman, D. 2006. Type 1 diabetes. <i>Lancet<\/i> 367: 847\u2013858.","DOI":"10.1016\/S0140-6736(06)68341-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Edgerton, D. S., Lautz, M., Scott, M., Everett, C. A., Stettler, K. M., Neal, D. W., Chu, C. A. and Cherrington, A. D. 2006. Insulin\u2019s direct effects on the liver dominate the control of hepatic glucose production. <i>J. Clin. Invest.<\/i> 116: 521\u2013527.","DOI":"10.1172\/JCI27073"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ewis, S. A. and Abdel-Rahman, M. S. 1995. Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats. <i>J. Appl. Toxicol.<\/i> 15: 387\u2013390.","DOI":"10.1002\/jat.2550150508"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Feitosa, A. C., Feitosa-Filho, G. S., Freitas, F. R., Wajchenberg, B. L. and Maranh\u00e3o, R. C. 2013. Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment. <i>Lipids Health Dis.<\/i> 12: 15\u201322.","DOI":"10.1186\/1476-511X-12-15"},{"key":"12","unstructured":"12. Feldman, E. C. and Nelson, R. W. 2004. Diabetes mellitus. pp. 486\u2013538. <i>In<\/i>: Canine and Feline Endocrinology and Reproduction, 3rd. ed., W.B. Saunders, Philadelphia."},{"key":"13","unstructured":"13. Fujimori, Y., Katsuno, K., Ojima, K., Nakashima, I., Nakano, S., Ishikawa-Takemura, Y., Kusama, H. and Isaji, M. 2009. Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats. <i>Eur. J. Pharmacol.<\/i> 609: 148\u2013154."},{"key":"14","unstructured":"14. Han, S., Hagan, D. L., Taylor, J. R., Xin, L., Meng, W., Biller, S. A., Wetterau, J. R., Washburn, W. N. and Whaley, J. M. 2008. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. <i>Diabetes<\/i> 57: 1723\u20131729."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Handlon, A. L. 2005. Sodium glucose co-transporter 2 (SGLT2) inhibitors as potential antidiabetic agents. <i>Expert Opin. Ther. Pat.<\/i> 15: 1531\u20131540.","DOI":"10.1517\/13543776.15.11.1531"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hediger, M. A., Coady, M. J., Ikeda, T. S. and Wright, E. M. 1987. Expression cloning and cDNA sequencing of the Na+\/glucose co-transporter. <i>Nature<\/i> 330: 379\u2013381.","DOI":"10.1038\/330379a0"},{"key":"17","unstructured":"17. Kapur, A., O\u2019Connor-Semmes, R., Hussey, E. K., Dobbins, R. L., Tao, W., Hompesch, M., Smith, G. A., Polli, J. W., James, C. D. Jr., Mikoshiba, I. and Nunez, D. J. 2013. First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus. <i>BMC Pharmacol. Toxicol.<\/i> 14: 26\u201336."},{"key":"18","unstructured":"18. Kashiwagi, A. 2001. Complications of diabetes mellitus and oxidative stress. <i>Japan Med. Assoc. J.<\/i> 44: 521\u2013528."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kahn, B. B. 1996. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. <i>Diabetes<\/i> 45: 1644\u20131654.","DOI":"10.2337\/diabetes.45.11.1644"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kim, S. K., Woodcroft, K. J., Khodadadeh, S. S. and Novak, R. F. 2004. Insulin signaling regulates \u03b3-glutamylcysteine ligase catalytic subunit expression in primary cultured rat hepatocytes. <i>J. Pharmacol. Exp. Ther.<\/i> 311: 99\u2013108.","DOI":"10.1124\/jpet.104.070375"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kulkarni, C. R., Joglekar, M. M., Patil, S. B. and Arvindekar, A. U. 2012. Antihyperglycemic and antihyperlipidemic effect of Santalum album in streptozotocin induced diabetic rats. <i>Pharm. Biol.<\/i> 50: 360\u2013365.","DOI":"10.3109\/13880209.2011.604677"},{"key":"22","unstructured":"22. Loghmani, E. 2005. Diabetes mellitus: type 1 and type 2. pp. 167\u2013182. <i>In<\/i>: Guidelines for Adolescent Nutrition Services (Stang, J. and Story, M. eds.), Center for Leadership, Education and Training in Maternal and Child Nutrition, Minneapolis."},{"key":"23","unstructured":"23. Luippold, G., Klein, T., Mark, M. and Grempler, R. 2012. Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus. <i>Diabetes Obes. Metab.<\/i> 14: 601\u2013607."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Mather, A. and Pollock, C. 2011. Glucose handling by the kidney. <i>Kidney Int. Suppl.<\/i> 79 120: S1\u2013S6.","DOI":"10.1038\/ki.2010.509"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. McCord, J. M., Keele, B. B. Jr. and Fridovich, I. 1971. An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. <i>Proc. Natl. Acad. Sci. USA<\/i> 68: 1024\u20131027.","DOI":"10.1073\/pnas.68.5.1024"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Novikova, L., Smirnova, I. V., Rawal, S., Dotson, A. L., Benedict, S. H. and Stehno-Bittel, L. 2013. Variations in rodent models of type 1 diabetes: islet morphology. <i>J. Diabetes Res.<\/i> 2013: 965832.","DOI":"10.1155\/2013\/965832"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Oliveira, G. O., Braga, C. P. and Fernandes, A. A. H. 2013. Improvement of biochemical parameters in type 1 diabetic rats after the roots aqueous extract of yacon [Smallanthus sonchifolius (Poepp.&amp; Endl.)] treatment. <i>Food Chem. Toxicol.<\/i> 59: 256\u2013260.","DOI":"10.1016\/j.fct.2013.05.050"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Pajor, A. M. and Wright, E. M. 1992. Cloning and functional expression of a mammalian Na+\/nucleoside cotransporter. A member of the SGLT family. <i>J. Biol. Chem.<\/i> 267: 3557\u20133560.","DOI":"10.1016\/S0021-9258(19)50557-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Park, K. S., Kim, J. H., Kim, M. S., Kim, J. M., Kim, S. K., Choi, J. Y., Chung, M. H., Han, B., Kim, S. Y. and Lee, H. K. 2001. Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. <i>Diabetes<\/i> 50: 2837\u20132841.","DOI":"10.2337\/diabetes.50.12.2837"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Quamme, G. A. and Freeman, H. J. 1987. Evidence for a high-affinity sodium-dependent D-glucose transport system in the kidney. <i>Am. J. Physiol.<\/i> 253: F151\u2013F157.","DOI":"10.1152\/ajprenal.1987.253.1.F151"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Rand, J. S., Fleeman, L. M., Farrow, H. A., Appleton, D. J. and Lederer, R. 2004. Canine and feline diabetes mellitus: nature or nurture? <i>J. Nutr.<\/i> 134 Suppl: 2072S\u20132080S.","DOI":"10.1093\/jn\/134.8.2072S"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Raptis, A. E. and Viberti, G. 2001. Pathogenesis of diabetic nephropathy. <i>Exp. Clin. Endocrinol. Diabetes<\/i> 109 Suppl 2: S424\u2013S437.","DOI":"10.1055\/s-2001-18600"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Renno, W. M., Abdeen, S., Alkhalaf, M. and Asfar, S. 2008. Effect of green tea on kidney tubules of diabetic rats. <i>Br. J. Nutr.<\/i> 100: 652\u2013659.","DOI":"10.1017\/S0007114508911533"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Saravanan, G. and Ponmurugan, P. 2011. Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats. <i>Chem. Biol. Interact.<\/i> 189: 100\u2013106.","DOI":"10.1016\/j.cbi.2010.10.001"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Schnedl, W. J., Ferber, S., Johnson, J. H. and Newgard, C. B. 1994. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. <i>Diabetes<\/i> 43: 1326\u20131333.","DOI":"10.2337\/diabetes.43.11.1326"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Shirwaikar, A., Rajendran, K., Dinesh Kumar, C. and Bodla, R. 2004. Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats. <i>J. Ethnopharmacol.<\/i> 91: 171\u2013175.","DOI":"10.1016\/j.jep.2003.12.017"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Son, S. M., Whalin, M. K., Harrison, D. G., Taylor, W. R. and Griendling, K. K. 2004. Oxidative stress and diabetic vascular complications. <i>Curr. Diab. Rep.<\/i> 4: 247\u2013252.","DOI":"10.1007\/s11892-004-0075-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tahara, A., Matsuyama-Yokono, A., Nakano, R., Someya, Y. and Shibasaki, M. 2008. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats. <i>Basic Clin. Pharmacol. Toxicol.<\/i> 103: 560\u2013568.","DOI":"10.1111\/j.1742-7843.2008.00321.x"},{"key":"39","unstructured":"39. Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., Kobayashi, Y., Noda, A., Sasamata, M. and Shibasaki, M. 2014. Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats. <i>J. Pharm. Pharmacol.<\/i> 66: 975\u2013987."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Turner, R. J. and Moran, A. 1982. Heterogeneity of sodium-dependent D-glucose transport sites along the proximal tubule: evidence from vesicle studies. <i>Am. J. Physiol.<\/i> 242: F406\u2013F414.","DOI":"10.1152\/ajprenal.1982.242.4.F406"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Wright, E. M. and Turk, E. 2004. The sodium\/glucose cotransport family SLC5. <i>Pflugers Arch.<\/i> 447: 510\u2013518.","DOI":"10.1007\/s00424-003-1063-6"},{"key":"42","unstructured":"42. Yamamoto, K., Uchida, S., Kitano, K., Fukuhara, N., Okumura-Kitajima, L., Gunji, E., Kozakai, A., Tomoike, H., Kojima, N., Asami, J., Toyoda, H., Arai, M., Takahashi, T. and Takahashi, K. 2011. TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity. <i>Br. J. Pharmacol.<\/i> 164: 181\u2013191."}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/82\/4\/82_19-0450\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,3]],"date-time":"2021-03-03T14:40:42Z","timestamp":1614782442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/82\/4\/82_19-0450\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.19-0450","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}